Nextmune

Global #1 in allergy diagnostics and treatment

A science-driven, speciality pharma company dedicated to allergy, dermatology and specialised nutrition

Global #1

In allergy testing and

allergy immunotherapy

70+

Sales in more than

70 countries

Premium offering

‘Gold standard’ allergy test and treatment

Evidence-based dermatology and nutrition

Global capabilities

Rapid turnaround time

Support & Expertise

Access to leading KOLs worldwide

Derm. / allergy veterinarians in Customer Service

GMP&USDA

GMP and USDA-certified facilities in Europe and US

Molecular Allergology: The future of IgE sensitisation detection

With CCD blocking and 2 blocking efficiency detectors

First quantitative multiplex macroarray specifically designed for horses

Expected increase in serological test sensitivity due to a higher concentration of molecular allergens

Over 200 allergen components + extracts included

= lower testing cost per allergen

Fully automated process = higher level of standardization

Identification of ”primary” sensitizing allergens

Identification of allergen cross-reactivities

Selection of relevant allergens for specific immunotherapy

Animal becomes
less sensitive or
even insensitive
to allergens

Only causal
treatment for atopic
dogs, cats and horses

Licensed ASIT
product of choice
 

Safe for long-term
treatment: virtually
no side effects
 

Tailor made for
each individual
patient

®

Dogs

Cats

Horses

75%

70%

84%

_____

_____

_____

PR® Allergone

✔ Innovative spray for neutralizing dust allergens

✔ Long-term protection (5 months)
✔ Easy to use

Allergone - Allergen neutralising spray

Dermoscent® Essential 6 Spot-On

✔ 100% natural active ingredients
✔ Antioxidants
✔ Dry skin, hair loss, dandruff and oily coat

Dr. Baddaky® Omega-3

Skin care for horses

Dermoscent® bio balm

✔ 100% natural active ingredients

✔ For damaged skin, skin irritations or skin thickenings and calluses

PR® Derm-10

✔ Wound cream with zinc oxide + 9 herbal extracts

✔ Works quickly and effectively

Wounds and risk areas

Nextmune  eye on patient, mind on innovation

UK

DE / AT / CH

ES / PT

NO / SE/ DK

Italy

+44 01494 629979

+49 4554 716 1237

+34 914 134 472

+47 62 83 29 00

+39 0373 982024

vetenquiries.uk@nextmune.com

info.de@nextmune.com

info.es@nextmune.com

post.no@nextmune.com

info.it@nextmune.com

NL / BE

+31 320 783 100

info.nl@nextmune.com

France

Export

+33 1 70 61 48 38

+31 320 783 100

info.fr@nextune.com

info.eu@nextmune.com

post.se@nextmune.com

post.dk@nextmune.com

info.be@nextmune.com